Mettler-Toledo International, Inc. $MTD Shares Sold by OFI Invest Asset Management

OFI Invest Asset Management trimmed its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 85.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 87 shares of the medical instruments supplier’s stock after selling 524 shares during the period. OFI Invest Asset Management’s holdings in Mettler-Toledo International were worth $102,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Vanguard Personalized Indexing Management LLC boosted its stake in Mettler-Toledo International by 10.7% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 3,075 shares of the medical instruments supplier’s stock valued at $3,613,000 after buying an additional 298 shares in the last quarter. Apollon Wealth Management LLC grew its holdings in Mettler-Toledo International by 3.9% during the second quarter. Apollon Wealth Management LLC now owns 349 shares of the medical instruments supplier’s stock worth $410,000 after acquiring an additional 13 shares during the period. Aberdeen Group plc grew its holdings in Mettler-Toledo International by 9.1% during the second quarter. Aberdeen Group plc now owns 17,910 shares of the medical instruments supplier’s stock worth $21,039,000 after acquiring an additional 1,496 shares during the period. L. Roy Papp & Associates LLP grew its holdings in Mettler-Toledo International by 3.6% during the second quarter. L. Roy Papp & Associates LLP now owns 10,242 shares of the medical instruments supplier’s stock worth $12,031,000 after acquiring an additional 359 shares during the period. Finally, IFP Advisors Inc grew its holdings in Mettler-Toledo International by 542.9% during the second quarter. IFP Advisors Inc now owns 90 shares of the medical instruments supplier’s stock worth $106,000 after acquiring an additional 76 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the sale, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,750,875. This trade represents a 5.56% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Gerry Keller sold 165 shares of the firm’s stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the sale, the insider owned 94 shares of the company’s stock, valued at $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,827 shares of company stock worth $2,371,208. 0.77% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. JPMorgan Chase & Co. lifted their target price on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a report on Thursday. Robert W. Baird lifted their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Evercore ISI lifted their target price on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Mettler-Toledo International in a report on Wednesday, October 8th. Finally, Bank of America increased their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research report on Monday, September 22nd. Five investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $1,336.50.

Mettler-Toledo International Stock Down 2.5%

NYSE:MTD opened at $1,274.39 on Monday. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,486.76. The firm has a market capitalization of $26.25 billion, a price-to-earnings ratio of 32.27, a price-to-earnings-growth ratio of 3.82 and a beta of 1.37. The stock has a fifty day simple moving average of $1,278.97 and a 200 day simple moving average of $1,190.01.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same quarter last year, the company posted $9.65 EPS. Mettler-Toledo International’s revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.